Combination of trastuzumab and pertuzumab with FOLFOXIRI as the neoadjuvant therapeutic tegimen for HER2-positive resectable metastatic colorectal cancer: The first case report

被引：2
|
作者：
Pang, Hua-Yang [1 ,2 ]
Yan, Meng-Yua [1 ]
Chen, Xiu-Feng [1 ]
Sun, Hao [1 ]
机构：
[1] Chongqing Univ, Canc Hosp, Dept Gastrointestinal Canc Ctr, Chongqing 400030, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing 400030, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 01期
关键词：
D O I：
10.1016/j.asjsur.2024.07.136
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 50 条
  • [31] Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
    Yu, Anthony F.
    Manrique, Carlos
    Pun, Shawn
    Liu, Jennifer E.
    Mara, Elton
    Fleisher, Amartin
    Patil, Sujata
    Jones, Lee W.
    Steingart, Richard M.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGIST, 2016, 21 (04): : 418 - 424
  • [32] Effect of pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer: A meta-analysis
    Tian, Tian
    Ye, Jing
    Zhou, Sihai
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (09) : 720 - 727
  • [33] Lapatinib after pertuzumab and ado-trastuzumab emtansine in metastatic HER2-positive breast cancer
    Baez-Vallecillo, L.
    Raghavendra, A. Singareeka
    Hess, K.
    Moulder, S. L.
    Tripathy, D.
    Valero, V.
    Murthy, R. K.
    CANCER RESEARCH, 2017, 77
  • [34] Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (03): : 84 - 86
  • [35] HER2-Positive Metastatic Colorectal Cancer
    Robinson, Hannah R.
    Messersmith, Wells A.
    Lentz, Robert W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (05) : 585 - 604
  • [36] HER2-Positive Metastatic Colorectal Cancer
    Hannah R. Robinson
    Wells A. Messersmith
    Robert W. Lentz
    Current Treatment Options in Oncology, 2024, 25 : 585 - 604
  • [37] Neoadjuvant Trastuzumab and Pertuzumab in Combination with Standard Chemotherapy for HER2-Positive Early Breast Cancer: Real-World Practice in Cuba
    Medina, Elias A. Gracia
    Caballero, Brenda Benitez
    Miguel, Karen Lopez
    Gutierrez, Zaili Aleaga
    Fernandez, Braulio Mestre
    Tul, Luis E. Alsina
    Rodriguez, Luis E. Martin
    Guerrero, Orlando Valdes
    Varela, Idania G. Sanchez
    Bernardo, Maria de la Caridad Campos
    Montero, Yoandri Calderon
    Ortiz, Monica Ramos
    Carrasco, Julien Martinez
    Torres, Keytia Pena
    Prado, Yenia I. Diaz
    Rubio, Maria Caridad
    Braojo, Ines M. Perez
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 34
  • [38] Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer
    Liu, Yan-cui
    Ma, Ying
    An, Ning
    Sun, Ping
    Wang, Ying
    Sun, Cheng
    MEDICINE, 2019, 98 (38)
  • [39] Cost-effectiveness of pertuzumab and trastuzumab as a first-line treatment of HER2-positive metastatic breast cancer in China
    Wang, Hao
    Wang, Ye
    Gong, Ruixue
    Geng, Yuyu
    Li, Li
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11382 - 11393
  • [40] Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer
    Qifei He
    Jiahui Chen
    Kai Zhou
    Chenggen Jin
    Anqiang Wang
    Ke Ji
    Xin Ji
    Ji Zhang
    Xiaojiang Wu
    Xia Li
    Zhaode Bu
    Jiafu Ji
    Annals of Surgical Oncology, 2021, 28 : 4413 - 4422
12345